Joint call

Aconym

Title

Coordinator

ADtest

Role of proteases and their inhibitors in pathophysiology and diagnosis of Alzheimer Disease

Markus Glatzel

(Germany)

EPITHERAPY

An epigenetic approach towards the recovery of neuronal network plasticity and cognitive function in neurodegenerative disease

Andre Fischer

(Germany)

ERMCC-NDEG

The activity-driven ER-mitochondria Calcium Cycle (ERMCC) and protein misfolding in neurodegenerative diseases: finding targets for therapy

Julian Grosskreutz

(Germany)

FamPD

Identification of new genes causing familial forms of PD

Thomas Gasser

(Germany)

heteropark

Synthesis and validation of antiparkinsonian drugs targeting GPCR heteromers

Rafael Franco

(Spain)

iPSoALS

Modeling sporadic ALS in motor neurons by genetic reprogramming of patient skin fibroblasts

Georg Haase

(France)

mGluRpatho

Group III metabotropic glutamate receptors (mGluRs): from new molecules to therapeutic development for the treatment of Parkinson's disease

Marianne Amalric

(France)

MIPROTRAN

Transfer of misfolded protein as a pathogenetic mechanism in neurodegenerative disease

Patrik Brundin

(Sweden)

nEUROsyn

Molecular mechanisms underlying synaptic dysfunction in prototypic neurodegenerative diseases related to protein misfolding

Fabrizio Tagliavini

(Italy)

PARKCDNF

Development of an experimental therapeutic strategy using the newly identified growth factor CDNF for treatment of Parkinson's disease

Kerstin Krieglstein

(Germany)

PhysiolDBS

Physiological mechanisms of Deep Brain Stimulation in Parkinson's disease

Jens Volkmann

(Germany)

ProGen

Protecting against neurodegeneration by somatic gene therapy

Thomas Arendt

(Germany)